AA
TNDM icon

AlphaMark Advisors’s Tandem Diabetes Care TNDM Stock Holding History

AlphaMark Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed -$1K – 812
2023
Q4 		$1K Hold
30
– – ﹤0.01% 700
2023
Q3 		$1K Hold
30
– – ﹤0.01% 710
2023
Q2 		$1K Hold
30
– – ﹤0.01% 602
2023
Q1 		$1K Hold
30
– – ﹤0.01% 595
2022
Q4 		$1K Hold
30
– – ﹤0.01% 567
2022
Q3 		$1K Buy
+30
New +$1.65K ﹤0.01% 660
2021
Q3 		– Sell
-40
Closed -$4K – 597
2021
Q2 		$4K Hold
40
– – ﹤0.01% 481
2021
Q1 		$4K Buy
+40
New +$3.72K ﹤0.01% 467

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

AlphaMark Advisors's TNDM Position: Q1 2024 in Review

AlphaMark Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 30 shares — an estimated $1K sold.

AlphaMark Advisors first reported a position in TNDM in Q1 2021 and held it in 8 quarters. The position peaked at $4K in Q2 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • AlphaMark Advisors reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 30 Tandem Diabetes Care shares in Q1 2024, an estimated $1K.
  • AlphaMark Advisors first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 8 quarters.
  • AlphaMark Advisors's Tandem Diabetes Care position peaked at $4K in Q2 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on AlphaMark Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.